Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Thiamine (vitamin B1) deficiency in the brain has been implicated in the development of dementia and symptoms of depression. Indirect evidence suggests that thiamine may contribute to these pathologies by controlling the activities of glycogen synthase kinase (GSK)-3β. While decreased G...
Auteurs principaux: | Markova, N, Bazhenova, N, Anthony, D, Vignisse, J, Svistunov, A, Lesch, K, Bettendorff, L, Strekalova, T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2016
|
Documents similaires
-
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels
par: Vignisse, J, et autres
Publié: (2017) -
Thiamine and benfotiamine: Focus on their therapeutic potential
par: Iva Bozic, et autres
Publié: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
par: O. A. Gromova, et autres
Publié: (2017-07-01) -
Benfotiamine Supplementation Increases Thiamine in Muscle of Endurance-Trained Mice and Affects the Energy Metabolism
par: Álisson C. Gonçalves, et autres
Publié: (2024-01-01) -
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
par: Julie K Hurt, et autres
Publié: (2012-01-01)